BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21834030)

  • 21. Discriminative Features in Three Autosomal Recessive Cutis Laxa Syndromes: Cutis Laxa IIA, Cutis Laxa IIB, and Geroderma Osteoplastica.
    Kariminejad A; Afroozan F; Bozorgmehr B; Ghanadan A; Akbaroghli S; Khorram Khorshid HR; Mojahedi F; Setoodeh A; Loh A; Tan YX; Escande-Beillard N; Malfait F; Reversade B; Gardeitchik T; Morava E
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28294978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and biochemical features guiding the diagnostics in neurometabolic cutis laxa.
    Gardeitchik T; Mohamed M; Fischer B; Lammens M; Lefeber D; Lace B; Parker M; Kim KJ; Lim BC; Häberle J; Garavelli L; Jagadeesh S; Kariminejad A; Guerra D; Leão M; Keski-Filppula R; Brunner H; Nijtmans L; van den Heuvel B; Wevers R; Kornak U; Morava E
    Eur J Hum Genet; 2014 Jul; 22(7):888-95. PubMed ID: 23963297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In silico screening, molecular docking, and molecular dynamics studies of SNP-derived human P5CR mutants.
    Sang P; Hu W; Ye YJ; Li LH; Zhang C; Xie YH; Meng ZH
    J Biomol Struct Dyn; 2017 Aug; 35(11):2441-2453. PubMed ID: 27677826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A de novo 1q23.3-q24.2 deletion combined with a GORAB missense mutation causes a distinctive phenotype with cutis laxa.
    Al-Bughaili M; Neuhann TM; Flöttmann R; Mundlos S; Spielmann M; Kornak U; Fischer-Zirnsak B
    J Hum Genet; 2017 Feb; 62(2):325-328. PubMed ID: 27604556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microcephaly-cardiomyopathy: a new autosomal recessive phenotype?
    Winship IM; Viljoen DL; Leary PM; De Moor MM
    J Med Genet; 1991 Sep; 28(9):619-21. PubMed ID: 1956062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in PYCR2, Encoding Pyrroline-5-Carboxylate Reductase 2, Cause Microcephaly and Hypomyelination.
    Nakayama T; Al-Maawali A; El-Quessny M; Rajab A; Khalil S; Stoler JM; Tan WH; Nasir R; Schmitz-Abe K; Hill RS; Partlow JN; Al-Saffar M; Servattalab S; LaCoursiere CM; Tambunan DE; Coulter ME; Elhosary PC; Gorski G; Barkovich AJ; Markianos K; Poduri A; Mochida GH
    Am J Hum Genet; 2015 May; 96(5):709-19. PubMed ID: 25865492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel de novo 1.8 Mb microdeletion of 17q21.33 associated with intellectual disability and dysmorphic features.
    Preiksaitiene E; Männik K; Dirse V; Utkus A; Ciuladaite Z; Kasnauskiene J; Kurg A; Kučinskas V
    Eur J Med Genet; 2012 Nov; 55(11):656-9. PubMed ID: 22842074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 1.6-Mb microdeletion in chromosome 17q22 leads to NOG-related symphalangism spectrum disorder without intellectual disability.
    Pang X; Luo H; Chai Y; Wang X; Sun L; He L; Chen P; Wu H; Yang T
    PLoS One; 2015; 10(3):e0120816. PubMed ID: 25815513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New autosomal recessive syndrome of mental retardation, coarse face, microcephaly, epilepsy and skeletal abnormalities.
    Battaglia A; Ferrari AR; Orsitto E; Gibilisco G; Neri G
    Clin Dysmorphol; 1996 Jan; 5(1):41-7. PubMed ID: 8867658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Speech impairment and the Smith-Magenis syndrome].
    Bergmann C; Morlot S; Ptok M
    HNO; 2007 Aug; 55(8):644-6. PubMed ID: 16767429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ring chromosome 17: phenotype variation by deletion size.
    Shashi V; White JR; Pettenati MJ; Root SK; Bell WL
    Clin Genet; 2003 Oct; 64(4):361-5. PubMed ID: 12974742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion 2q31.2-q31.3 in a 4-year-old girl with microcephaly and severe mental retardation.
    Manolakos E; Vetro A; Kefalas K; Thomaidis L; Aperis G; Sotiriou S; Kitsos G; Merkas M; Sifakis S; Papoulidis I; Liehr T; Zuffardi O; Petersen MB
    Am J Med Genet A; 2011 Jun; 155A(6):1476-82. PubMed ID: 21567918
    [No Abstract]   [Full Text] [Related]  

  • 33. PYCR2 Mutations cause a lethal syndrome of microcephaly and failure to thrive.
    Zaki MS; Bhat G; Sultan T; Issa M; Jung HJ; Dikoglu E; Selim L; G Mahmoud I; Abdel-Hamid MS; Abdel-Salam G; Marin-Valencia I; Gleeson JG
    Ann Neurol; 2016 Jul; 80(1):59-70. PubMed ID: 27130255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Siblings with chromosome mosaicism, microcephaly, and growth retardation: the phenotypic expression of a human mitotic mutant?
    Tolmie JL; Boyd E; Batstone P; Ferguson-Smith ME; al Roomi L; Connor JM
    Hum Genet; 1988 Oct; 80(2):197-200. PubMed ID: 3169747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Array-CGH revealed one of the smallest 16q21q22.1 microdeletions in a female patient with psychomotor retardation.
    Tsoutsou E; Tzetis M; Giannikou K; Syrmou A; Oikonomakis V; Kosma K; Kanioura A; Kanavakis E; Fryssira H
    Eur J Paediatr Neurol; 2013 May; 17(3):316-20. PubMed ID: 23352671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The neuropsychiatry and multisystem features of the Smith-Magenis syndrome: a review.
    Shelley BP; Robertson MM
    J Neuropsychiatry Clin Neurosci; 2005; 17(1):91-7. PubMed ID: 15746488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers.
    Ding J; Kuo ML; Su L; Xue L; Luh F; Zhang H; Wang J; Lin TG; Zhang K; Chu P; Zheng S; Liu X; Yen Y
    Carcinogenesis; 2017 May; 38(5):519-531. PubMed ID: 28379297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smith-Magenis syndrome.
    Finucane BM; Jaeger ER
    Ophthalmology; 1997 May; 104(5):732-3. PubMed ID: 9160013
    [No Abstract]   [Full Text] [Related]  

  • 39. Additional case of de novo interstitial deletion del(17)(q21.3q23) and expansion of the phenotype.
    Khalifa MM; MacLeod PM; Duncan AM
    Clin Genet; 1993 Nov; 44(5):258-61. PubMed ID: 7906212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analyses of LMNA-negative juvenile progeroid cases confirms biallelic POLR3A mutations in Wiedemann-Rautenstrauch-like syndrome and expands the phenotypic spectrum of PYCR1 mutations.
    Lessel D; Ozel AB; Campbell SE; Saadi A; Arlt MF; McSweeney KM; Plaiasu V; Szakszon K; Szőllős A; Rusu C; Rojas AJ; Lopez-Valdez J; Thiele H; Nürnberg P; Nickerson DA; Bamshad MJ; Li JZ; Kubisch C; Glover TW; Gordon LB
    Hum Genet; 2018 Dec; 137(11-12):921-939. PubMed ID: 30450527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.